Collection: Available Now
Available for immediate download.
-
FDA NDA 020103, ZOFRAN, SANDOZ, 12/31/1992
Regular price $1,737.63 USDRegular priceUnit price / per -
FDA NDA 050684, ZOSYN, WYETH PHARMS, 10/22/1993
Regular price $1,945.94 USDRegular priceUnit price / per -
FDA NDA 070292, CARBACHOL, Pharmafair
Regular price $271.73 USDRegular priceUnit price / per -
FDA NDA 201094, GLYDO, SAGENT PHARMS INC, 04/28/2014
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 208232: CDER€™s DGE Division's response to OOPD regarding Mycapssa (dated 4/5/24)
Regular price $51.94 USDRegular priceUnit price / per -
FDA NDA 209637, OZEMPIC, NOVO, 12/05/2017
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 209988, FUROSCIX, SCPHARMACEUTICALS, 10/07/2022
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 214755: Review Files for the supplemental NDA application for Lumryz
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 215256, WEGOVY, NOVO, 06/04/2021
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 215866, MOUNJARO (AUTOINJECTOR), ELI LILLY AND CO, 05/13/2022
Regular price $9.95 USDRegular priceUnit price / per -
FDA NDA 216354, AUSTEDO XR, TEVA, 02/17/2023
Regular price $9.95 USDRegular priceUnit price / per -
FDA SSED for PMA P910071, ADATOMED SILICONE OIL OP5000
Regular price $178.95 USDRegular priceUnit price / per -
NDA 208232 Orphan Drug Designation Letter for Mycapssa (6/17/10)
Regular price $9.95 USDRegular priceUnit price / per -
Submissions to FDA from EyePoint Pharmaceuticals, Inc. regarding the 02/2024 Inspection
Regular price $0.00 USDRegular priceUnit price / per